Additionally, the 36-month beta value for YTEN is 1.62. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for YTEN is 0.53M and currently, short sellers hold a 0.07% ratio of that float. The average trading volume of YTEN on May 10, 2024 was 127.26K shares.
YTEN) stock’s latest price update
The stock price of Yield10 Bioscience Inc (NASDAQ: YTEN) has surged by 17.40 when compared to previous closing price of 5.00, but the company has seen a 6.71% gain in its stock price over the last five trading sessions. Seeking Alpha reported 2024-04-01 that Yield10 Bioscience, Inc. (YTEN) Q4 2023 Earnings Call Transcript
YTEN’s Market Performance
YTEN’s stock has risen by 6.71% in the past week, with a monthly drop of -26.55% and a quarterly drop of -7.70%. The volatility ratio for the week is 22.48% while the volatility levels for the last 30 days are 14.77% for Yield10 Bioscience Inc The simple moving average for the past 20 days is -1.78% for YTEN’s stock, with a -37.25% simple moving average for the past 200 days.
Analysts’ Opinion of YTEN
H.C. Wainwright, on the other hand, stated in their research note that they expect to see YTEN reach a price target of $25. The rating they have provided for YTEN stocks is “Buy” according to the report published on September 10th, 2020.
National Securities gave a rating of “Buy” to YTEN, setting the target price at $15 in the report published on August 27th of the previous year.
YTEN Trading at -12.94% from the 50-Day Moving Average
After a stumble in the market that brought YTEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.57% of loss for the given period.
Volatility was left at 14.77%, however, over the last 30 days, the volatility rate increased by 22.48%, as shares sank -23.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.08% lower at present.
During the last 5 trading sessions, YTEN rose by +6.71%, which changed the moving average for the period of 200-days by -86.71% in comparison to the 20-day moving average, which settled at $5.89. In addition, Yield10 Bioscience Inc saw 2.21% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at YTEN starting from SCHULER JACK W, who sale 36,000 shares at the price of $0.21 back on Dec 19 ’23. After this action, SCHULER JACK W now owns 1,566,956 shares of Yield10 Bioscience Inc, valued at $7,430 using the latest closing price.
SCHULER JACK W, the 10% Owner of Yield10 Bioscience Inc, sale 35,000 shares at $0.24 during a trade that took place back on Dec 08 ’23, which means that SCHULER JACK W is holding 1,602,956 shares at $8,320 based on the most recent closing price.
Stock Fundamentals for YTEN
Current profitability levels for the company are sitting at:
- -120.14 for the present operating margin
- -2.33 for the gross margin
The net margin for Yield10 Bioscience Inc stands at -120.31. The total capital return value is set at 15.05. Equity return is now at value -1508.09, with -241.08 for asset returns.
Based on Yield10 Bioscience Inc (YTEN), the company’s capital structure generated 4.57 points at debt to capital in total, while cash flow to debt ratio is standing at -3.17. The debt to equity ratio resting at -1.28. The interest coverage ratio of the stock is 800.94.
Currently, EBITDA for the company is -14.13 million with net debt to EBITDA at -0.15. When we switch over and look at the enterprise to sales, we see a ratio of 49.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.29.
Conclusion
In conclusion, Yield10 Bioscience Inc (YTEN) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
